By combining immunotherapy targeting the innate and adaptive immune systems, researchers have been able to eliminate large, established tumors in animal models. The four-component therapeutic strategy will "certainly not [be] trivial to translate," co-corresponding author Darrell Irvine told BioWorld Today. But the work is proof of principle that "there is some combination treatment in immunotherapy that allows the elimination of the majority of large tumors in animal models."